Dehydroeburicoic Acid, a Dual Inhibitor against Oxidative Stress in Alcoholic Liver Disease
Alcoholic liver disease (ALD) is a complicated disease which can lead to hepatocellular carcinoma; however, there is a lack of satisfactory therapeutics. Dehydroeburicoic acid (DEA) (<b>1</b>), a triterpenoid isolated from <i>Antrodia cinnamomea</i>, has been reported to act...
Saved in:
Main Authors: | Shasha Cheng (Author), Yi Kuang (Author), Guodong Li (Author), Jia Wu (Author), Chung-Nga Ko (Author), Wanhe Wang (Author), Dik-Lung Ma (Author), Min Ye (Author), Chung-Hang Leung (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of a cytisine-based EED-EZH2 protein-protein interaction inhibitor preventing metastasis in triple-negative breast cancer cells
by: Shasha Cheng, et al.
Published: (2022) -
Aurone derivatives as Vps34 inhibitors that modulate autophagy
by: Guodong Li, et al.
Published: (2019) -
Computational strategies for PROTAC drug discovery
by: Jia Wu, et al.
Published: (2023) -
Inhibition of the CDK9-cyclin T1 protein-protein interaction as a new approach against triple-negative breast cancer
by: Sha-Sha Cheng, et al.
Published: (2022) -
A robust luminescent assay for screening alkyladenine DNA glycosylase inhibitors to overcome DNA repair and temozolomide drug resistance
by: Ying-Qi Song, et al.
Published: (2023)